Ozempic 1 MG/dose (4 MG/3 ML) 3ML
Ended Awarded
- Contract number
- SPE2DB25FJZ31
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,528
Award facts
- Contract value 100% obligated
- $18,527.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On September 17, 2025, the Defense Logistics Agency awarded a delivery order valued at $18,527.65 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 ml) in 3 ml vials. This firm fixed price delivery order, with an ultimate completion date of September 18, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The award is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
This delivery order supports the Defense Logistics Agency's medical supply chain operations by providing a diabetes medication critical for military and veteran healthcare systems. Ozempic is a brand-name pharmaceutical product within AmerisourceBergen Drug Corp's extensive portfolio of deliverables under the SPE2DX prime indefinite delivery contract, which encompasses specialty medications, generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The competitive award reflects the contractor's demonstrated capability to meet federal procurement requirements and supports the agency's mission to supply necessary pharmaceuticals to Defense Health Agency beneficiaries and other government healthcare systems worldwide.
Quick answers
Who was awarded contract SPE2DB25FJZ31?
SPE2DB25FJZ31 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 17, 2025.
How much is contract SPE2DB25FJZ31 worth?
The government has obligated $18,528 on SPE2DB25FJZ31.
Is contract SPE2DB25FJZ31 an order under another contract?
Yes. SPE2DB25FJZ31 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJZ31 competed?
The extent of competition for SPE2DB25FJZ31 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award